Benzinga's M&A Chatter for Monday July 27, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday July 27, 2015:

:

Teva Pharmaceutical Industries Ltd.

announced Monday, that it will acquire Allergan Generics

for $40.5 billion. Upon closing, including $33.75 billion in cash and $6.75 billion in shares of Teva. The deal is expected to close in Q1 of 2016. Teva also announced that it has withdrawn its cash and stock proposal to acquire Mylan N.V.

and won't pursue a transaction with Mylan at this time. Allergan CEO Brent Saunders said on the conference call that the company may use the cash from the Teva deal for M&A. Amgen Inc.

and AbbVie Inc.

are potential targets, according to

. Teva closed at $72.00 on Monday, a gain of 16.5%. Allergan shares gained 6%, closing at $326.98.

:

Xueda Education Group

announced Monday, that Xiamen Insight Investment Co., Ltd. will acquire Xueda for $5.50 in cash per ADS. The deal, is expected to close in Q4 of 2015 Xueda shares closed at $4.82 Monday, a gain of 50%.

:

McGraw Hill Financial

announced Monday, that it has agreed to acquire SNL Financial for approximately $2.225 billion in cash. The deal is expected to close in Q3 of 2015, McGraw Hill Financial closed at $99.59 on Monday, down $5.99.